The peptide is structurally derived from native human GLP-1(7-37) with two amino acid substitutions (Aib at position 8 for DPP-IV resistance, Arg substitution at position 34) and a C18 fatty diacid moiety conjugated via a Glu-(AEEA) linker enabling reversible albumin binding and an extended pharmacokinetic profile compatible with once-weekly dosing
Understanding where your current dose falls in the progression helps you anticipate upcoming adjustments and recognize that intermediate doses are intentional steps, not final maintenance levels
Their compact size facilitates improved dermal permeation and sustained release, increasing therapeutic efficacy and minimizing unintended effects
It's packed with immunoglobulins, growth factors, and compounds that strengthen gut barrier function, support immune health, and reduce exercise-induced intestinal permeabilitycritical for endurance athletes.
Incapsula incident ID: 242000750095966520-35702259261248202
You'll receive full training on how to administer the medication and have access to our team for ongoing support